Table 1.
Clinical and Epidemiological characteristics of living and deceased donors
| uEV Analysis | Age | Gender | HTA | DM2 | DLP | Others | SrCr (mg/dL) | Remuzzi Score | Cause of death | Drugs | ICU Drugs | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RK | LK | ||||||||||||
| LD1 | P,T | 40–45 | F | – | – | – | – | 0.7 | – | – | – | – | – |
| LD2 | P,T | 55–60 | F | – | – | – | – | 0.98 | – | – | – | – | – |
| LD3 | P,T | 65–70 | M | – | – | – | – | 0.63 | – | – | – | – | – |
| LD4 | P,T | 50–55 | M | – | – | Yes | Hipotirodism | 0.93 | – | – | – | simvastatin, Levotiroxine | – |
| LD5 | P,T | 55–60 | F | – | – | – | – | 1.02 | – | – | – | – | – |
| DD1 | P, T | 65–70 | F | Yes | – | Yes | – | 0.8 | 3 | 3 | CVA | Olmesartan, Lormetazepam | noradrenaline, furosemide |
| DD2 | P, T | 65–70 | F | – | Yes | – | obesity | 0.8 | 5 | 5 | Ictus | metformine, insuline | clopidogrelt, amoxiciline-clavulanic |
| DD3 | P,T | 80–85 | F | Yes | – | Yes | – | 1.5 | 4 | 5 | CVA | bisoprolol,torasemide, lorazepam, sertralin, simvastatin | – |
| DD4 | T | 75–80 | M | Yes | Yes | Yes | – | 1.8 | 4 | 4 | Trauma | Triflusal;enalapril; Metformin; Gliclazide; Ezetimibe; Allopurinol; Glucosamine; Tenoxicam; Omeprazole | manitol, actocortine, noradrenaline, |
| DD5 | T | 55–60 | M | Yes | – | – | – | 1.56 | 2 | – | Cardiac event | Losartan, Atorvastatin, fenofibrate | propofol, atropine, midazolam, noradrenaline |
| DD6 | P | 45–50 | M | – | – | – | Bone cyst | 3.41 | 2 | 2 | PTE | oxcarbazepine, diazepam, Celecoxib. | adrenaline |
| DD7 | P | 70–75 | F | – | – | Yes | osteoporosis | 0.73 | 3 | 2 | Ictus | Calcium | noradrenaline |
A summary of the age, gender, diseases, cause of death and medication of all the patients is included in this Table. P: sample used for proteomic assays. T: sample used for NGS assays
F female, M male; HTA Hypertension, DM2 Diabetes Mellitus type 2, DLP Dyslipemia, CVA cerebrovascular accident, PTE Pulmonary thrombo-embolism, SrCr Serum Creatinine, RK right kidney, LK left kidney